» Articles » PMID: 23743750

The Effects of Hyperbaric Oxygen Therapy Upon Ototoxic Injuries Produced by Amikacin in Guinea Pigs

Overview
Date 2013 Jun 8
PMID 23743750
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Hyperbaric oxygen therapy (HBOT) has enhanced the prevention and treatment of auditory ailments such as ototoxicity.

Objective: To study the effects of HBOT upon ototoxic injuries produced by amikacin.

Method: This experimental study included 12 albino guinea pigs, whose auditory function was assessed through distortion product otoacoustic emissions (DPOAEs) and brainstem auditory evoked potentials (BAEPs) before and after the administration of amikacin (600 mg/kg/day) and HBOT sessions (2 ATA, 60 minutes). Morphological features were analyzed through scanning electron microscopy. Subjects were divided into four groups, as follows: group 1 - saline solution + HBOT; group 2 - amikacin for 8 days; group 3 - amikacin + seven days of rest; and group 4 - amikacin + HBOT.

Results: Group 1 subjects had preserved function and morphology throughout the experiment; Group 2 subjects had statistically significant levels of hair cell injury and functional impairment; Subjects on groups 3 and 4 had statistically significant functional and morphological impairment after the administration of amikacin, which were still present after the proposed procedures had been carried out.

Conclusion: Hyperbaric oxygen therapy did not change the cochlear hair cell morphology or the electro-physiological thresholds of the guinea pigs given amikacin.

Citing Articles

Is Hyperbaric Oxygen Therapy Effective in Cisplatin-Induced Ototoxicity in Rats?.

Cobanoglu H, Vuralkan E, Arslan A, Mirasoglu B, Toklu A Clin Exp Otorhinolaryngol. 2018; 12(1):66-71.

PMID: 30189717 PMC: 6315209. DOI: 10.21053/ceo.2017.01704.


FoxO3a plays a key role in the protective effects of pomegranate peel extract against amikacin-induced ototoxicity.

Liu S, Zhang X, Sun M, Xu T, Wang A Int J Mol Med. 2017; 40(1):175-181.

PMID: 28560451 PMC: 5466397. DOI: 10.3892/ijmm.2017.3003.


An Evaluation of the Protective Effects of Thymoquinone on Amikacin-Induced Ototoxicity in Rats.

Aksoy F, Dogan R, Ozturan O, Tugrul S, Veyseller B, Ozer O Clin Exp Otorhinolaryngol. 2015; 8(4):312-9.

PMID: 26622947 PMC: 4661244. DOI: 10.3342/ceo.2015.8.4.312.


Sensorineural deafness following routine transurethral resection of the prostate.

Bowsher B BMJ Case Rep. 2015; 2015.

PMID: 26564118 PMC: 4654020. DOI: 10.1136/bcr-2015-212933.

References
1.
de Aquino T, Oliveira J, Rossato M . Ototoxicity and otoprotection in the inner ear of guinea pigs using gentamicin and amikacin: ultrastructural and functional aspects. Braz J Otorhinolaryngol. 2009; 74(6):843-852. PMC: 9445930. DOI: 10.1016/S1808-8694(15)30144-0. View

2.
Sharp P, Saenz C, Martin R . Amikacin (BB-K8) treatment of multiple-drug resistant Proteus infections. Antimicrob Agents Chemother. 1974; 5(5):435-8. PMC: 428989. DOI: 10.1128/AAC.5.5.435. View

3.
Hotz M, Harris F, Probst R . Otoacoustic emissions: an approach for monitoring aminoglycoside-induced ototoxicity. Laryngoscope. 1994; 104(9):1130-4. DOI: 10.1288/00005537-199409000-00014. View

4.
Murakawa T, Kosaka M, Mori Y, Fukazawa M, Misaki K . [Treatment of 522 patients with sudden deafness performed oxygenation at high pressure]. Nihon Jibiinkoka Gakkai Kaiho. 2000; 103(5):506-15. DOI: 10.3950/jibiinkoka.103.506. View

5.
Selimoglu E . Aminoglycoside-induced ototoxicity. Curr Pharm Des. 2007; 13(1):119-26. DOI: 10.2174/138161207779313731. View